For all three tissues, for both FOS and JUN, we had relatively large numbers of peaks in each file to compare with the 4,102 promoters of interest, providing an excellent dataset for testing the hypotheses that these TFs occupy the promoters preferentially in MET versus non-cancer cells and in MET versus Non-MET cancer, but not in Non-MET versus non-cancer cells. This evidence concerns the gene FOS and cancer.